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Executive Summary
Comparison of Home Medication Adherence in Adults Age 65 and Older After
Completion of Standardized Discharge Medication Education or Non-Standardized
Discharge Medication Education
Problem
The older patient (age 65 and older) is at higher risk of medication induced illness
because of numerous co-morbid conditions treated with multiple medications, a standardized
approach to medication education at hospital discharge can reduce adverse medication events for
this at risk population (Esposito, 1995; Jack et al., 2009). The primary driving force for this
project is the limited number of research studies published to date that include this specific age
bracket and setting. It is clear the aging population is at risk for adverse medication events
(Esposito, 1995; Holloway, 1996; Jack et al., 2009; Laugaland et al., 2012). What is unclear is
what the most effective approach to meeting the educational needs of the aging population is.
Purpose
Based on this identified problem, the PICO (P, population, I, intervention, C, comparison,
O, outcome) question served to focus the Capstone Project, for adults aged 65 and above, would
a standardized discharge education program for medication management versus no standardized
program be effective in increasing patient adherence to home medication regimen, as measured
by telephone questionnaire at one week and again at three to six weeks post discharge.
Goals
The general project focus was to create a standardized discharge medication education
program for older adults. The specific focus was to improve patient compliance with their
complex medication regimen. The expectation, is with improved compliance there will also be a
decrease in adverse events, improvement of patient self-efficacy, increase patient understanding
of their medication regimen, and subsequently reduce hospital readmission rates and resource
utilization.
Objectives
The primary project objective was to increase patient adherence of home medication
regimen by 25% in the intervention group as evidenced by improvement in scores using a
modified CASE adherence index.
Plan
The study was a two group design interventional study, one group receiving “standard”
hospital discharge medication education and an “intervention” group. Participants were a
convenience sample of hospital patients, chosen by chance. The education program for the
intervention group included three facets of “tactile” information combined with verbal education.
A pill dispenser was provided to the participants of the intervention group. A phone
questionnaire was performed at one week and three to six weeks post discharge for all
participants, using the modified CASE adherence index to determine medication compliance.
Outcomes, Results, and Recommendations
The intervention did not make a statistically significant difference between two group
total scores overall. Question one, week one and three, showed the most improvement (p= .334
and p= .031 respectively) indicating the participants are taking their medications correctly and
retaining the education at three weeks post discharge for this sample. This project provides a
framework for additional research on this topic with a larger sample size and longer data
collection period.
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As medications play a large role in the treatment of many medical conditions, adherence
to those medications is vital. This capstone project discusses adults age 65 and older, identified
as a vulnerable population, and the benefits of a standardized approach to discharge medication
education program in a hospital setting.

Problem Recognition and Definition

Individuals older than 65 years are the most active consumers of health care, and this group continues to incr
projected population of people 65 and older in 2050 is 88.5 million, compromising 20 percent of
the total US population at that time (United States Census Bureau, 2012). Patient medication
education is a large component of discharge planning and one of many standards necessary for a
hospital to attain accreditation (The Joint Commission, 2015). However, there is often a lack of
patient education and information regarding medication, resulting in patients being discharged
with inadequate preparation (Holloway, 1996). The purpose of this project was to demonstrate
improved medication compliance in adults age 65 and older, with the use of a standardized
discharge medication education program.
The older patient (age 65 and older) is at higher risk for a medication induced illness
because of numerous co-morbid conditions treated with multiple medications, prescribed by
multiple providers (Esposito, 1995; Jones, Treiber, & Jones, 2014). A standardized approach to
medication education at hospital discharge can reduce adverse medication events for this at risk
population (Jack et al., 2009). Based on this identified patient care issue, the PICO (P,
population, I, intervention, C, comparison, O, outcome) question that served as the basis for this
research project, for adults aged 65 and above, would a standardized discharge education
program for medication management versus no standardized program be effective in increasing
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patient adherence to home medication regimen, as measured by telephone questionnaire at one
week and again at three to six weeks post discharge? This was a standardized quality
improvement initiative, not intended to develop new knowledge or be generalized outside of the
agency. The project was an evidence-based practice (EBP) project in which a quality
improvement plan, educational, and standard of care intervention will be completed. A pretest/post-test evaluation assessed the effect of the intervention. The project will be internal to an
agency and will inform the agency of issues regarding health care quality. The results of this
project were not meant to generate new knowledge or be generalizable across settings but rather
seek to address a specific population, at a specific time, in a specific agency. This project
translated and applied the science of nursing to the greater health care field.
This project utilized the acronym “PICO”, rather than stating a formal research
hypothesis. The acronym stands for: Population or Disease (P), Intervention or Issue of Interest
(I), Comparison group or Current Practice (C), and Outcome (O) and is usually framed as a
question (Melnyk & Fineout-Overholt, 2011, p. 31). The question this study seeks to address is:
P: Older adults, aged 65 and above
I: Developing a standardized discharge education program for medication management
C: No standardized discharge education program in place
O: Increased compliance with home medication regimen evidenced by results of phone
questionnaire performed at one week and again at three to six post discharge.
The PICO question is: Would standardized discharge medication education improve
home medication adherence in adults age 65 and older compared to non-standardized discharge
medication education?
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The topic of patient education is paramount to any nursing field, specifically the
advanced practice role. As an advanced practice nurse, prescription medications and their
subsequent adherence are part of the complexity involved when speaking to disease
management. Appropriate and comprehensive education has potential to improve patient
compliance, subsequently improving patient health and well-being. The benefit of a solid
education program is not limited to only one practice, or hospital setting. In the author’s opinion,
a program of this type has the ability to be used universally throughout the medical community
(Jones et al., 2014; Miner, 2015). The role of an advanced practice nurse, or doctorate prepared
nurse, is unique in its dual role as nurse and provider. Duality leads to increased potential for
choices made to impact the nursing profession as well as the patient population.
There are numerous advanced practice nursing outcome measures the project addressed:
care, patient, and performance related (Kleinpell, 2013). The general project focus was to create
a standardized discharge medication education program for older adults. The specific focus was
to improve patient adherence with their medication regimen. The expectation was, with
improved adherence, there would also be a decrease in adverse events, improvement of patient
self-efficacy, increased patient understanding/knowledge of their medication regimen, and
subsequently reduced hospital readmission rates and resource utilization.
Theoretical Framework
Perhaps the most important theoretical foundation for this practice issue was Adult
Learning Theory by Malcolm Knowles. This theory is based on the principle adults need certain
considerations to successfully learn (Syx, 2008). The six primary concepts are:
1. Adults need to know why they need to know something before they start
2. As adults mature they become more self-directed and less dependent in their actions
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3. Personal experience is a large resource for learning new information
4. Adults are problem oriented learners
5. An adults time frame changes from postponed action to immediate action
6. Adults are primarily motivated by a need to solve immediate and practical problems
(McEwen & Wills, 2011; Syx, 2008)
These principles were intentionally incorporated in this project. This was accomplished by
clearly outlining each item within the consent form and discussion with each participant of the
project. To be effective patient educators, one must be familiar with the appropriate theoretical
foundation to optimize learning. Theories provide a framework that can be adapted to each
patient’s needs. A healthcare provider can educate their using a combination of theories.
Through this process arises the opportunity for the achievement of optimal patient outcomes.
Having an effective grasp of these concepts will assist in making any educational effort more
successful.
The Theory of Self-Care Management for Vulnerable Populations by Dorsey and
Murdaugh (2003) was additionally applicable to this practice issue. They define a vulnerable
population as “social groups who experience disparities as a result of a lack of resources and
increased exposure to risk” (Dorsey & Murdaugh, 2003, p. 43). The major concepts noted
include contextual factors, vulnerability, intra-personal factors, self-care management, health
status, and quality of life (Dorsey & Murdaugh, 2003). The older patient is vulnerable largely
due to the number co-morbid conditions treated with multiple medications, which are prescribed
by multiple providers (Esposito, 1995; Jones, Treiber, & Jones, 2014). This alone places the
patient at risk for adverse complications, increased hospital utilization, and death. The theory
posits people with a chronic illness encounter both modifiable and non-modifiable factors that
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may increase their vulnerability. Effective management of chronic disease thus would assist in
the control of this modifiable factor. Therefore, one could surmise that a comprehensive
education program offers the patient the best chance at effective management of their medication
regimen consequently increase patient control of their health and quality of life.
Prevention as Intervention by August-Brady (2000) is the method through which one acts
to accomplish the goal of client/system stability. Three concepts exist within the Prevention as
Intervention Theory: a) assessment of actual or potential stressors; b) Prevention strategiesprimary, secondary, tertiary; and c) health-client system stability (August-Brady, 2000). The
prevention strategies in this model can be used synchronously or individually to achieve the
desired outcome. This theory correlates closely with Adult Learning Theory and the educational
program being designed as the education provided was a prevention strategy designed to prevent
complications from mismanagement of medications and/or worsening disease states.
The Health Belief Model, developed in the 1950s by Hochbaum and colleagues, also
provided framework to the foundation of this education program. There are three major premises
noted: individual perceptions, modifying factors, and likelihood of action (Syx, 2008). This
theory was developed with the idea people fear disease, and their health actions are based upon
that fear, as well as, the benefit attained from making healthy choices (McEwen & Wills, 2011).
This model works well with this practice issue, as education about consequences of not adhering
to prescribed medication regimen are included in the program and supportive of Adult Learning
theory.
Pender’s Health Promotion Model was applicable to this practice issue, as the plan was to
promote compliance with medication regimen utilizing a thorough education program. Major
concepts of this model are “individual characteristics and experiences, behavior-specific
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cognition and affect, and behavioral outcomes” (McEwen & Wills, 2011, p. 225). Personal
experiences affect behaviors, which in turn will affect outcomes (Syx, 2008). Giving the patient
a positive educational experience can increase their chance of applying education in an effective
manner.
Systematic Review of Evidence: Literature Review
A systematic literature review of 150 articles was completed. After review, 36 articles
were chosen to provide a foundation of reference material related to the project. Data was
obtained from CINAHL database using keywords: discharge medication education, discharge
summary, aged, drug prescriptions, educational intervention, drug therapy, drug toxicity, patient
compliance, patient non-adherence, compliance, elderly, hospital readmissions, adherence,
inappropriate prescribing, treatment review, patient education, resident education, transitional
care, hospital discharge summary, discharge planning, resident training, communication,
electronic medical record, collaboration, medication error, self-care, self-management, and selfmedication. The data reviewed included one interventional trial, one survey, four randomized
controlled trials, eight literature reviews, one ethnographic study, one expert opinion, one
practice report, three prospective intervention studies with retrospective controls, three quasiexperimental designs, three single descriptive studies, four qualitative studies, two prospective
randomized parallel-group open-label trials, two observational studies, one retrospective cohort,
and one quality improvement project. The literature was narrowed to support the topic of the
aging population and discharge education regimens (Appendix A).
The underlying theme noted within each article reviewed was that standardized
education, to some degree, improves patient outcomes (Doggrell, 2010; Esposito, 1995;
Holloway, 1996; Martens, 1998). The data documented various modalities to educate patients

7

about their home medication regimen. One randomized, controlled trial evaluated the clinical
effects of implementing a reengineered discharge program for patients admitted to a general
medical service (Jack et al., 2009). This trial decreased readmissions and hospital utilization
within 30 days of discharge by 30% among study participants (Jack et al., 2009). One survey
concluded the participants had insufficient knowledge and information concerning their
discharge medications (Holloway, 1996). An interventional trial, specifically focused on the
older adult (>65 years old), presented the participants who had a medication schedule given to
them upon discharge had a reduced incidence of medication error than to those who did not have
the intervention (Esposito, 1995).
A literature review to categorize interventions designed to improve patient safety at
discharge among the elderly found that simple tools were most effective to reduce readmission
rates and decrease adverse drug events. These tools include the use of structured discharge
reports, verbally verified checklists, education performed by pharmacy staff, and post hospital
discharge follow up by medical staff (Laugaland, Aase & Branch, 2012). A prospective
intervention study with retrospective controls exhibited the use of a prescription report at
discharge decreased the need for medical care post-discharge due to medication errors (Midlov,
Deierborg, Holmdahl, Hoglund, & Eriksson, 2008).
While patient education was performed using varying methodologies the outcomes
appeared similar. A standardized and multi-faceted approach to discharge medication education
for the older adult can decrease adverse events and improve patient outcomes.
Market/Risk Analyses
SWOT
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A Strength, Weakness, Opportunities, and Threat (SWOT) analysis was performed to
further objectify the project outcomes (Fortenberry, 2010).
Strengths of the project included:
1. A large potential group of participants to draw from in this setting was desired.
2. The author estimated 80% of current practice population was > 65 years of age
3. Of those patients, 90% or more left the hospital setting with a new prescription
4. Lastly, the lack of benchmark studies pertaining to this particular age group (Jack
et al., 2009).
Weaknesses of the project included:
1. Data obtained from single medical center
2. Small sample size
3. Data obtained using a convenience sample
4. Results are not generalizable
5.

Complexity of the participants medication regimen

6. Patient education level
7. The relationship of the patient with their primary care provider.
Opportunities found within the project included:
1. Increase number of the “aging” population in medical settings
2. Limited time for proper patient education using “dated” or unstructured
techniques
3. The ability to be adapted at any facility/setting for minimal out-of-pocket cost.
Threats to the success of the project included:
1. Financial limitations
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2. Transportation issues to obtain medications
3. Interaction with a home health agency
4. Family support
5. Patient medication compliance (Appendix B)
The primary driving force for this project was the limited number of studies performed to
date that included this specific age bracket and setting. There are no benchmarks to draw upon.
There are no reference points to begin with. It is clear the aging population is at risk for adverse
medication events (Esposito, 1995; Holloway, 1996; Jack et al., 2009; Laugaland et al., 2012).
What is unclear is what the most effective approach to meeting the educational needs of the
aging population with a standardized discharge medication education regimen. The restraining
forces of the project were the financial limitations of the project developer as well as the
generalizability of the study findings.
The need for a project of this type has been clearly defined by the lack of studies specific
to this patient population (Esposito, 1995; Holloway, 1996; Jack et al., 2009; Laugaland et al.,
2012). Resources necessary to complete this project were few. The project designer performed
the patient education at discharge as well as the follow-up telephone calls to the project
participants. The author spent approximately three hours per week providing education to
participants and completing follow-up phone calls to perform the survey questionnaire. The
author calculated the results of the study using IBM SPSS version 23. The author purchased the
monthly medication pill dispensers to distribute them to the appropriate study participants. The
sustainability of the study was very manageable, as the project length was short, participants
limited by the hospital census, and minimal cost to complete the study. The sustainability for a
hospital to institute the project into the daily nursing care are limited to the costs of the
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medication dispensers (should they ultimately be provided by the facility), as the nursing staff is
already budgeted for patient care.
Project Team and Stake Holders
The project team includes the author and her capstone chair at Regis University, Dr.
Christine Finn; Kristie Agee RN, BSN mentored throughout the project, providing insight and
alternative viewpoints; and Jackie DeSouza, Chief Executive Officer at Research Medical
Center, granted approval for project completion. The stakeholders included the medical facility
staff and providers where the project was completed, to include nursing staff and patients, as it
could prove to be an improvement to their current discharge practice.
Cost Benefit Analysis
A brief cost-benefit analysis indicates a 28 day pills dispenser cost approximately $5.00.
This was calculated using an average of cost for dispensers found at two local retail pharmacy
stores. The cost of medical care varies state to state, as does the cost of emergency room visits
and hospital stays. As such, the actual dollars “saved” by preventing adverse drug events cannot
be quantified. However, recent studies indicate 11% of hospital admissions in the greater
than/equal to 65 age group are a result of medication errors with this number increasing to 26%
in those over age 75 (Doggrell, 2010). An average cost for a hospital stay for a patient 65 or
older nationally is estimated to be a mean of $10,000 per stay (HCUP, 2013)
Project Objectives
The Vision of the project was to have a positive effect on patient outcomes with an easy
to use, standardized discharge medication education regimen with minimal financial burden to
the patient/client. The primary project objective was to increase patient adherence of home
medication regimen by 25% in the intervention group as evidenced by improvement in scores
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using a modified Center for Adherence Support and Evaluation (CASE) adherence index
(Appendix C).
Logic Model
The author could not find a benchmark. There is no nationally accepted standardized
discharge medication education regimen (Esposito, 1995). However numerous clinical trials and
clinical studies have been performed addressing a standardized discharge medication education
program. These studies and clinical trials address general patient education, as well as education
specific for older adults (Appendix A).
One randomized clinical trial reviewed utilized a nurse discharge advocate who worked
with patients during their hospital stay to coordinate follow-up appointments, confirm accurate
medication reconciliation, and perform patient education with an individualized instruction
booklet sent to their primary care provider (Jack et al., 2009). A clinical pharmacist then called
patients two to four days after discharge to reinforce the discharge plan and review medications
(Jack et al., 2009). The control group of patient’s received “usual” care upon discharge, with no
follow up phone call from any staff of the facility. The intervention group demonstrated a
decrease in hospital readmission rates and emergency room (ER) visits 30 days after discharge
(Jack et al., 2009).
An additional study by Esposito (1995) utilized as a comparison benchmark of sorts,
specific to the “elderly” population. This study was chosen for reference, despite the age, as it
was the only study that was demographically similar to the current project. It was an intervention
study to evaluate educational protocols to see which would be more effective in increasing
medication compliance rates with an elderly population. Forty-two patients were randomized
into four groups. Group one received a standard education protocol, group two received the
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standard education and 30 minutes of verbal instruction, group three received the standard
education and a medication schedule, and group four received the standard education, a
medication schedule, and 30 minutes of verbal instruction. The intervention was accomplished
on the day of hospital discharge. Home visits were made two weeks, one and two month’s posthospital discharge. Results of the visits revealed that groups one and two had higher rates of
errors with medications than groups three and four. The groups with a medication schedule had
higher compliance rates (Esposito, 1995).
There are numerous advanced practice nursing outcome measures this project addresses,
including care-, patient-, and performance related (Kleinpell, 2013). However, the specific focus
is to improve patient compliance with their medication regimen. Most health care professionals
know how difficult this can be, and how it varies from patient to patient. Society is getting
"older"(Doggrell, 2010). Often times, a myriad of medications are needed to control co-morbid
conditions. The goal of the project, is with improved compliance there will also be a decrease in
adverse events, improvement of patient self-efficacy, increase patient understanding/knowledge
of their medication regimen (the why and the how or what they are taking), and subsequently
reduce hospital readmission rates and resource utilization (Kane & Radosevich, 2011).
Through a thorough systematic review of supporting literature, the author was optimistic
to create a successful education program using components of various studies that demonstrated
positive outcomes. Below is a conceptual logic model that served as a foundation for the project
(Zaccagnini & White, 2014). The project was the creation of a standardized discharge
medication education program for adults age 65 and older. The model identified the problems the
aging adult can face upon hospital discharge when sub-optimal medication education is
dispensed. Problems include adverse medication events, increased hospital re-admission rates,
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lack of patient medication education, incorrect medication intake, increased financial/medical
burden and death.
Numerous resources impacted the identified problem. These resources include staff
participation, complexity of the patient’s medication regimen, compliance/time for hospital staff
to perform education, and patient education level. Outside of the hospital setting resources
impacting the problem include the patient’s relationship with their PCP, financial limitations,
transportation to obtain medications, interaction with a home health agency and family support.
Next identified were the activities, or interventions, that would affect the success of the
program. The activities within a conceptual model include the processes, techniques, tools, and
planned actions within a proposal (Zaccagnini & White, 2014). Activities included staff
education of the project goals. Also, delivery of pill dispenser, creation of an individualized
medication calendar and medication educational handouts for participants in the intervention
group. Additionally, patient education was performed at discharge for those in the intervention
portion of the project. Project completion occurred with a follow up phone call one week and
three to six weeks post discharge for all project participants.
The outputs in a conceptual model reflect the direct result of the programs activities
(Zaccagnini & White, 2014). The outputs in this project included the number of patients
educated, education materials distributed, program participation rates, and time spent with each
participant.
The final two portions of the logic model show the outcomes, as well as the impact of the
project. Logic Models show short and long term goals that address the specific changes in
attitudes, behaviors, skills, or knowledge that result from the program implementation
(Zaccagnini & White, 2014). The short-term goals of this proposal included increased patient
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medication adherence and increased patient knowledge of medication regimen. Long-term goals
included decreased hospital readmission rates, increased quality of life and decreased financial
burden.
In conclusion, the model presents the impact of the project. The impact goal of this
project included change in hospital policy/procedure at facility of project implementation,
increased longevity of patient, improved QOL, decreased utilization of medical resources, and
the potential to affect discharge education process at all areas facilities within the corporation
(Table 1).

Table 1: Logic Model

Problem Identification
Adverse medication events
Hospital re-admission rates
Lack of patient medication education
Incorrect medication intake
Financial/medical burden
Death
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Resources
Staff participation
Complexity of medication regimen
Patient education level
Relationship with PCP
Compliance/Time to perform education
Financial limitations
Transportation to obtain medications
Interaction with a home health agency
Family support

Activities

Outputs

Outcomes

Impact

Staff education
Pill dispenser
Medication
calendar
Educational
handouts
Patient education at
discharge
Phone call follow
up at one week and
again at one month
post discharge

Number of patients
educated
Education materials
distributed
Program
participation rates
Time spent with
each participant

Short termIncreased
medication
adherence
Increased patient
knowledge of
regimen
Long termDecreased hospital
readmission rates
Increased QOL
Decreased financial
burden

Change in hospital
policy/procedure at
current facility
Increased longevity
of patient
Improved QOL
Decreased
utilization of
medical resources
Affect discharge
education process
at all areas facilities
within corporation

Methodology
The study was a quasi-experimental two group design interventional study, one group
receiving “standard” hospital discharge medication education and the second an “intervention”
group. Participants for the project were drawn from a convenience sample of hospital patients,

16

chosen by chance. The independent variable associated with this practice issue was the
implementation of a standardized discharge education program for medication management. No
study has evaluated a standardized discharge intervention that included patient education,
comprehensive discharge planning, and post-discharge telephone reinforcement in a general
medical population since the Jack et al. (2009) study. Geriatric education centers have identified
a lack of communication by the health care provider as a contributing factor to medication errors
by the patient (Esposito, 1995). A simple solution to this issue was the creation of a standardized
medication education program that all facilities can use at discharge.
The education program had three facets of “tactile” information combined with verbal
education :
1. Each patient was given a monthly or weekly pill dispenser, ensuring that it was easy to
open and manipulate by the patient.
2. A weekly/monthly calendar was furnished to the patient, plotting out the times of day
all medications were to be taken. If a drug was to be dosed in intervals, these days were shaded a
different color, i.e. Monday, Wednesday, Friday dosing of warfarin were shaded blue on the
calendar (Jack et al., 2009; Martens, 1998). (Appendix E)
3. Medication information handouts listing how and when to take each medication, as
well as general information about each drug. Benefits of adhering to medication regimen as
prescribed were included as well. These handouts were written at an eighth grade reading level
with 18 point font size (Appendix F)
The dependent variable associated with the practice issue was increased compliance with
home medication regimen evidenced by results of phone questionnaire performed at one week
and again at three to six weeks post discharge. Understanding compliance does lie primarily with
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the patient; health care providers can provide numerous adjuncts to further assist the process.
Improved compliance with medication regimens are associated with:
1. Simple clear instructions, reviewed periodically
2. Written instructions
3. Assessment of cognitive function prior to education
4. Development of a routine for taking medications
5. Construction of a chart when multiple medications are taken (Esposito, 1995, p. 936).
Laugaland, Aase, and Branch (2012) found a review of the data demonstrated a positive
correlation between the independent and dependent variables by use of simple tools. The less
complex the intervention, the higher probability the patient will be receptive and successful.
Successful interventions reduce hospital readmission rates, adverse drug events, health care
utilization, medication induced illness, increased patient/family satisfaction, and decrease cost
(Esposito, 1995; Holloway, 1996; Laugaland et al., 2012).
Potential antecedent variables to this practice issue included age, number of chronic
medical conditions requiring medication (co-morbidities), complexity of medication regimen,
patient education level, relationship with primary care provider, and compliance. Potential
moderator variables included age, culture/ethnicity, past experience with similar programs,
financial limitations, gender, compliance, dexterity, education level, and hearing/visual/auditory
impairment. Extraneous variables included financial limitations, transportation issues to obtain
medications, interaction with a home health agency, family support, and compliance (Esposito,
1995; Holloway, 1996; Laugaland et al., 2012).
Patients were selected from the hospital admission roster for the selected practice at the
selected facility. Patients were not excluded from the selection process due to number of
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medications taken daily or number of medical conditions. Extra time was allotted for participants
with greater than five daily medications, as a review of their medications occupied more time
than a patient who only takes one medication daily. As there is no cost to the patient to
participate, financial limitations were not issue, as they were given the necessary elements for the
project free of charge. Antecedent and moderator variables were further addressed by evaluating
participants for enrollment in the study using the following inclusion criteria:
1. Age 65 or older
2. Hospitalized for at least 24 hours, but no longer than three days due to time
constraints of the project
3. Patient must be oriented to person, time, and place
4.

Discharged to home

5. Ability to self-administer medications or take with minimal assistance
6. No cognitive impairments
7. Able to comprehend instructions written in English, at an eighth grade reading level
(Esposito, 1995).
The participants were drawn from a convenience sample of hospital patients who were
discharged and meet the inclusion criteria. Figuring the lowest possible number of participants
necessary to maintain a confidence level of 95% with a confidence interval of five, a minimum
of 26 participants total was necessary for power in this project
(http://www.gpower.hhu.de/en.html). Thus, the sample size was 26, or n= 26. A sample size of
100 was sought through the facility’s institutional review board (IRB) for the purposes of this
study. Participants were identified by their age (target group age equal to or greater than 65 years
old) and approached regarding participation in the project. During the explanation about the
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project, the participant was assessed regarding inclusion criteria. Exclusion criteria included
patients with dementia or other disorders affecting cognitive impairment, those receiving
hospice/palliative care, those patients undergoing active chemotherapy or radiation therapy,
patients less than 65 years of age, and those with a hospital stay greater than three days.
This project involved protected data of a vulnerable population. The surveyor had access
to participant medications and basic demographics for use in the data collection process. No
names or participant identifiers were included in the project summary, only alpha characters
assigned to each participant at the beginning of the project were recorded.
Regarding protection of human subjects, all project team members, including the author
and project lead chair, successfully completed the Collaborative Institutional Training Initiative
(CITI). The expiration dates for current certification expires in 2017. Responsibilities to the
participants included protecting their medical and personal information, fully disclosing the
purpose of the project, and assuring that their medical care would not be affected regardless of
their consent to participation in the project (Appendix D). The project did not involve any testing
on individuals or manipulation of their medications. The main purpose was only collecting data
as it pertained to participant compliance or adherence to their prescribed regimen. As such,
exempt status was obtained from the Regis IRB.
Participants for the project were drawn from a convenience sample of hospital patients,
chosen by chance. On the day(s) the project was performed, each patient name that met the
inclusion criteria was listed on a single piece of paper. The total number of participants was
tallied and divided in half. All of the paper with the patient name was folded in half then placed
into a box. A single piece of paper at a time was drawn from the box and placed in the control
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folder, until half of the names were drawn. The remaining names in the box were placed in the
intervention folder.
Once the participants were divided into their respective groups, and prior to categorizing
data, all participants were given a letter associated with their profile. Control group members had
a single alpha character, and the intervention group members had a double alpha character.
Profile information included name, age, and gender. This particular set of patient data was kept
in a secure locked office area to prevent violations of patient privacy. For the purposes of this
project, a secure area was defined as a password protected computer and/or a locked file cabinet
in the project lead’s home office. A spreadsheet was then created to categorize data. Along the
left side of the spreadsheet, the participants names were listed as their “letter” identifier, along
the top of the spreadsheet had each question listed. Two separate spreadsheets were created for
the control group and the intervention group. Once information was entered, a score was
calculated and listed in the final column of the spreadsheet.
Project Variables, Design, and Data Collection Plan
The proposed project was a two group design interventional study, chosen by chance, one
group of participants received “standard” hospital discharge medication education and an
“intervention” group received additional verbal education, instructional handouts, and a
medication dispenser. Non-parametric, descriptive statistics were used to evaluate the ordinal
and nominal data (Polit & Hungler, 1995). Bivariate analysis was used to determine the
relationship between the control and intervention group (Polit & Hungler, 1995). The data were
analyzed with Statistical Package for the Social Sciences (SPSS) version 23.0 Grad Pack for
Windows and displayed in the final study report using frequency tables and pie charts to
compare data values (SPSS inc., Chicago IL).
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The measure of compliance was deduced using a modified CASE adherence index
(Mannheimer et al., 2006). The original author reported it may be reproduced and/or used for
research, teaching, and private study purposes (Mannheimer et al., 2006). The questionnaire was
modified, making it more applicable to the project, by omitting the word HIV in the questions.
The project mentor and Capstone chair agreed this would not affect the reliability of the tool
(Appendix C). The answers to the three question survey were allocated numbers. Once the
survey was completed, the numbers were summed and an adherence score was attached to said
number. A score of greater than 10 indicated “good” adherence, and a number less than or equal
to 10 indicated poor adherence (Mannheimer et al., 2006).
The modified survey was administered to all project participants to determine if the
intervention group scores demonstrated increased medication compliance. The scores from the
survey were compiled and calculated to create a percentage of patients who were in the “good”
adherence category and those who fall into the “poor” adherence category. These numbers were
compared between the two groups to determine if the intervention exhibited an increase in home
medication compliance. The comparisons were made by taking the total scores for each group
and then dividing that number by the number of participants in each group, control and
intervention. Information gathered from these surveys was used to show effects of a standardized
discharge medication regimen
A power analysis was performed for the proposed plan. Researchers typically use power
analysis to solve for the sample size needed to increase the chance of showing significant results
(Polit & Hungler, 1995). To solve for sample size, the researcher must specify the significance
criterion, population effect size, and power (Polit & Hungler, 1995). Statistical power is critical
to the design and planning of an outcomes study; therefore it should be conducted in advance
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through a priori power analysis (Kane & Radosevich, 2011). Set standards for considering
statistical power include setting the risk of type one error (or alpha) as 0.05, and a conventional
standard for power (1-beta) as 0.8 (Polit & Hungler, 1995). Utilizing an online tool, the
completed analysis has identified a total study sample of 26
(http://www.gpower.hhu.de/en.html). The participants were then divided into the control group
and the intervention group, chosen by chance. The author determined to have a significance
criterion (alpha) of 0.05 and a .80 power, a minimum sample size of 26 total for each group
combined participants was needed for the project (Kane & Radosevich, 2011, Polit & Hungler,
1995). A sample size of 100 was sought for approval for completion of this project to ensure
adequate sample.
Statistical research has varying levels of threats, including those of reliability and validity
(Polit & Hungler, 1995). Threats to reliability were minimized by using a standardized survey
instrument to report participant information. The sensitivity and specificity of the CASE
Adherence Index with respect to three -day self-reported adherence was calculated at different
cut-off scores by the original author. Based on this analysis, a cutoff score of 10 on the CASE
Adherence Index was used to dichotomize the CASE Adherence Index to maximize the
sensitivity and specificity of the index with respect to the three-day self-report set at 95%
adherence. Threats to internal validity were limited by using four steps:
1. Ensured measurement or observation used standard instruments
2. Used an appropriate study design
3. Controlled bias
4. Accurate statistical analysis (Cullen, 2011)
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The project used a standardized adherence rating questionnaire to decrease threat to
internal validity. The study design was a two group design interventional study utilizing a
convenience sample available within the author’s primary medical practice. Discharge education
is a highly variable event with many contributing factors. These factors can include time of day
discharge is performed, patient comprehension level, caliber of staff nurse, pharmaceutical
knowledge-base of staff nurse, cognitive barriers, and physical handicaps of the patient limiting
comprehension. Having a sole investigator perform the education limited the variability of the
education administered to study participants.
Potential threats to reliability or validity were participants reporting inaccurate data to
avoid judgment or perceived threats to care, participants not returning calls after consenting to
participate, mental status changes that occurred post discharge which affected cognition of the
survey, and family assistance with complying with medication regimen. Bias was avoided using
specific verbiage in the consent to participate in the program, including language to inform
patients their care would not be affected in any way by participating in the project and they could
withdraw at any time without change in care.
To mitigate threats, a maximum of three phone calls were made to the participants to obtain
survey data. Participants were given verbal reinforcement during each call that their responses,
or lack thereof, would in no way affect the medical care they received. Participants were
encouraged during each call about the importance of reporting accurate data for the purposes of
the project.
Careful selection of study data displays enhanced the understanding of the significance of
study results and reduced all possibility of obscuring or misrepresenting the data (Freeman,
Walters & Campbell, 2011). There were several considerations for displaying data in a way that
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augmented the discussion of the study results. Data were displayed in the final study report in
frequency tables and pie charts that compare data values (Figure I, Table II, Appendix F, and
Appendix G). The modified CASE survey used in the study is included as Appendix C
(Mannheimer et al., 2006).

Timeline
A timeline was a tool utilized to guide the forward progression of the project. The project
was submitted for approval by capstone chair in November 2014, followed by institutional
review board (IRB) application completed January 1, 2014. IRB submission/approval from
project site and Regis University was obtained April 2015. Data collection was performed April
1 to June 8, 2015. Data analysis, final capstone project written paper, and oral capstone defense
followed culminating into the submission to the library for publication in August 2015.
Budget
The expense for this project will vary between facilities and locations. Costs for the
project included:
•

$130.00 for pill dispensers, 26 dispensers at $5.00/unit

•

$198 for SPSS program used to perform data analysis

•

$1,000.00 for computer with MS Office software and locked filing cabinet

•

$90,000.00 annual salary for advanced practice registered nurse, pro-rated for
time necessary to complete project which was 4 months total.

Estimates were made from an average of products found in retail chain office supply stores.
Actual salary for advance practice registered nurse used, can be pro-rated to time necessary for
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project completion and varies location to location, this is an averaged salary estimate. The final
cost therefore, was $31,328.

Data Analysis
The Sample
After review of 100 potential candidates for participation, 16 met inclusion criteria with a
final N=16. Those 16 were divided equally into control and intervention groups (eight in each
group), chosen by chance. The participants were admitted to the hospital between April 2015 and
June 2015.
Data was entered and analyzed utilizing SPSS version 23. Descriptive statistics were used
to examine the percentages of categorical variables (age) and comparison of data between
control and intervention groups. Demographic data was analyzed for descriptive statistics
including median, mode, and percentile range. Independent t-tests were performed for
comparison of mean data between control and intervention groups.
The participants of the study were aged 66 to 82, with the mean age of 73.13 years (Figure I).
Twenty-five percent of the participants were age 69 or less (Table II).
Figure I
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Table II
Age

Cumulative
Frequency
Valid

Percent

Valid Percent

Percent

66

1

6.3

6.3

6.3

67

1

6.3

6.3

12.5

68

1

6.3

6.3

18.8

69

1

6.3

6.3

25.0

71

3

18.8

18.8

43.8

72

3

18.8

18.8

62.5

73

1

6.3

6.3

68.8

77

2

12.5

12.5

81.3

80

1

6.3

6.3

87.5

82

2

12.5

12.5

100.0

16

100.0

100.0

Total

Protection of Human Subjects
This project involved protected data of a vulnerable population. The surveyor had access
to participant medications and basic demographics for use in the data collection process. No
names or participant identifiers were included in the project summary, only alpha characters
assigned to each participant at the beginning of the project were recorded.
Once the participants were placed into their respective groups, and prior to categorizing
data, all participants were given a letter associated with their profile. Control group members had
a single alpha character, and the intervention group members had a double alpha character.
Profile information included name, age, and gender. This particular set of patient data was kept
in a secure locked file cabinet in a locked office area to prevent violations of patient privacy. For
the purposes of this project, a secure area was defined as a password protected computer and/or a
locked file cabinet in the project lead’s home office.
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All project team members, including the author and project lead chair, successfully
completed the Collaborative Institutional Training Initiative (CITI). All information related to
this project will be destroyed after five years. The data will be destroyed using a paper shredder.
Findings and Results Discussion
An Independent T-test compared participants who received “standard” discharge
medication education and those who received an additional education that combined three facets
of “tactile” information with verbal education. There was no statistically significant
improvement in the cumulative scores of those who received “standard” discharge medication
education and those in the intervention group. However, there was notable improvement when
comparing the week one (all groups) and week three (all groups) scores pertaining to question
one of the survey (Appendix G). Results demonstrated a change in significance from week one
(p= .334) to week three (p=.031) respectively. Question two scoring showed no significant
change from week one to week three. Question three did show a slight decrease in overall
significance in comparing week one (p=.215) and week three (p= .314). The weakest points of
the study were related to “missed” doses of the participant’s medications evidenced in the
cumulative scores from question two and question three and lack of change in overall
significance (Appendix F).
Effect Size
The magnitude of a relationship in situations calling for independent group t-tests is most
often communicated in the form of effect size, as it measures the strength of the relationship
between variables in the population (Polit, 2010). This statistic is referred to as Cohen’s d. The
effect size, or Cohen’s d was calculated for the individual questions and the total cumulative
scores, comparing the control and intervention groups. The results include:
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The Cohen’s d was .24 for week one and .56 for week three pertaining to question
one.



The Cohen’s d was .00 for week one and .00 for week three pertaining to question
two.



The Cohen’s d was .27 for week one and .22 for week three pertaining to question
three.



The Cohen’s d was .28 for week one and .32 for week three for the cumulative
scores.

According to Cohen’s criteria, an effect size of .20 in a two-group mean-difference
situation is considered small, .50 is medium, and .80 is large (Polit, 2010). Based on the data
above the estimated effect size is small, with the exception of question one/week three. This
question showed an estimated medium effect size, which was reflective of the results obtained
from the independent t-test.
Reliability
When researchers are interested in assessing an instrument’s stability over time, the test is
administered on two separate occasions to determine test-retest reliability (Polit, 2010). The
correlation coefficient between the total scores in week one and week three provide evidence of
the instrument’s reliability (Appendix F, Appendix G).
Utilizing a standardized questionnaire to document participant responses increased the
reliability of the data obtained overall. However, discharge education is a highly variable event
with many contributing factors that could impact the outcomes of the “standard” education
group. These factors can include time of day discharge is performed, patient comprehension
level, caliber of staff nurse, pharmaceutical knowledge-base of staff nurse, cognitive barriers,
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and physical handicaps of the patient limiting comprehension. Having a sole investigator
perform the education limited the variability of the education administered to the intervention
group.
Threats to reliability were minimized by using a standardized survey instrument to report
participant information. The sensitivity and specificity of the CASE Adherence Index with
respect to three -day self-reported adherence was calculated at different cut-off scores by the
original author (Mannheimer et al., 2006). Based on this analysis, a cutoff score of 10 on the
CASE Adherence Index was used to dichotomize the CASE Adherence Index to maximize the
sensitivity and specificity of the index with respect to the three-day self-report set at 95%
adherence (Mannheimer et al., 2006).
The initial study used the data obtained from the survey and correlated the results to
laboratory data. The published questionnaire had a reliability and validity published by the
author reporting the CASE Adherence Index correlated strongly with the three-day self-reported
adherence data (p < 0.001) and was more strongly associated with human immunodeficiency
virus (HIV) outcomes (p < 0.05), and performed as well as the three-day self-report when
predicting CD4 count status (Mannheimer et al., 2006). Participants with a CASE Index score
>10 achieved a 98 cell mean increase in CD4 count over 12 months, compared to a 41 cell
increase for those with scores ≤10 (p < 0.05) (Mannheimer et al., 2006).
Validity
The concept of validity refers to how close the measure is to actually measuring what was
intended (Polit, 2010). Validity is the extent to which a conclusion or measurement is wellfounded and corresponds accurately to the real world. This questionnaire at weeks one and three
measured the participants’ medication adherence. The published questionnaire had a reliability
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and validity published by the author reporting the CASE Adherence Index correlated strongly
with the three-day self-reported adherence data (p < 0.001) and was more strongly associated
with HIV outcomes (p < 0.05) (Mannheimer et al., 2006).
Discussion
Although there was a change in the total scores between the control and intervention
group, it was not statistically significant. However, statistically significant differences existed in
the overall scoring of question one/week one and question one/week three. This theorizes
participants were retaining information regarding the importance of medication adherence even
after three weeks following education. The results of this small study could be used as a
foundation for additional studies that support the creation of a “standard” discharge program.
Even though this was a small sample size and did not reached the expected power, one could
summarize based upon the published literature and the beginnings of movement to increased
adherence that this is a study that warrants repeating using a larger sample size.
Discharge education is a highly variable event with many contributing factors. These
factors can include time of day discharge is performed, patient comprehension level, caliber of
staff nurse, pharmaceutical knowledge-base of staff nurse, cognitive barriers, and physical
handicaps of the patient limiting comprehension. Having a sole investigator perform the
education limited the variability of the education administered to study participants.
Evidence-based Practice Questions
Analysis was conducted of the question: Would a standardized discharge education
program for medication management versus no standardized program be effective in increasing
patient adherence to home medication regimen, as measured by telephone questionnaire at one
week and again at three to six weeks post discharge. The study results did illustrate the additional
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education components the intervention group received did have an impact on patient medication
adherence, albeit not statistically significant. A clinically significant increase in adherence is
important even if not statistically significant. Medication non-adherence is considered a threat to
the physical, mental and economic health of the United States (Jones et al., 2014). Adverse
health outcomes related to poor medication adherence can range from exacerbations of disease
processes to premature death as well as resulting in increased utilization of healthcare resources
thus patient safety continues to be a concern (Jack et al., 2009; Jones et al., 2014).
Theoretical Support
The data did display a notable improvement in the overall week one scores, despite the
lack of significant changes in the overall scoring. This does support the Adult Learning Theory
by Malcolm Knowles that recommends certain information be used to enhance/improve the
educational experience of the adult learner. This theory is based on the principle adults need
certain considerations to successfully learn (Syx, 2008).
1.

Adults need to know why they need to know something before they start

2.

As adults mature they are more self-directed and less dependent

3.

Personal experience is a large resource for learning new information

4.

Adults are problem oriented learners

5.

An adults time frame changes from postponed action to immediate action

6.

Adults are primarily motivated by a need to solve immediate and practical

problems
Limitations
Limitations included a small sample size within one health care facility. Approval was
sought for 100 participants total in the research project. However, only 16 participants met
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inclusion criteria during the allotted time frame for data collection. This limitation decreases the
ability of findings to be generalized outside of this setting. Limiting the study to the three months
could also be consider at limitation as seniors are hospitalized during different seasons with
varying diagnoses.
Contributions to Nursing Advanced Practice
Continuation of this education initiative would be of benefit to any healthcare facility.
The results do illustrate there is increased retention of medication education at three weeks post
discharge. There are numerous reasons a program such as this could potentially benefit seniors at
any healthcare facility. With improved medication adherence, there would also be a decrease in
adverse events, improvement of patient self-efficacy, increased patient understanding/knowledge
of their medication regimen, increased patient well-being and subsequently reduced hospital
readmission rates and resource utilization thus increased patient satisfaction and quality of life
(Doggrell, 2010; Jack et al., 2009; Jones et al., 2014; Midlov et al., 2008).
Recommendation for Further Study
Despite a small sample size, the project does demonstrate a probable positive correlation
between a standardized discharge medication regimen and improved medication adherence once
discharged from a facility. A study with a larger sample size, a longer collection period, along
with broadening the inclusion criteria could increase the ability to generalize these results. The
weakest points of the study were related to “missed” doses of the participant’s medications. This
indicates an educational opportunity for focused education about the importance of not only
taking a medication on time, but also not missing doses of medications. There are a number of
ways to improve upon this aspect of the study.
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Additional measures could include written-information sheets, structured discharge
medication education, medication calendars, supplementation of medication dispensers with up
to four times daily dosing, increased verbal counseling, and increased utilization of additional
resources (i.e. pharmacists or pharmacy technicians). Any, or all, of these additional processes
might improve patient’s understanding of their medication regimen, resulting in increased
medication adherence and safer use of medications by the patient. When combined with current
medication education practice, these additional measures can only benefit the health and safety
of any patient, regardless of their age.
Implications for Change
Non-adherence to prescribed medication therapies has no predilection for age, gender or
ethnicity. Non-adherence impacts the overall health and well-being, short and long-term, for
anyone using prescription medication for a medical condition (Jones et al., 2014). Initiating a
standardized medication education regimen in acute care settings is a beneficial tool to improve
medication adherence thus leading to increase patient quality of health.
Conclusion
Education could be considered one of the most important duties a practitioner has to their
patient. Generally speaking, the goal of patient education is for the patient to not only understand
their health condition but also how to properly manage said condition(s). Management of a comorbid condition is largely achieved with proper medication administration and this burden often
lies with the patient or their family. A comprehensive medication education program is a logical
solution for something that has potential to be so detrimental to a patient’s health.
The findings of the project demonstrate a possible positive correlation between a
standardized discharge medication regimen and improved medication adherence once discharged
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from a facility. A study with a larger sample size, a longer collection period, along with
broadening the inclusion criteria could increase the ability to generalize these results. With
further research studies, a stronger positive correlation could be found between a standardized
discharge medication education that could significantly impact patient’s quality of life and health
care understanding.
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Appendix B
SWOT analysis
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Appendix C
CASE (Center for Adherence Support and Evaluation) Adherence Index questionnairemodified
Please ask each question and circle the corresponding number next to the answer, then add up the
numbers circled to calculate Index score.
A1. How often do you feel that you have difficulty taking your medications on time? By ‘on time’ we
mean no more than two hours before or two hours after the time your doctor told you to take it.
4 Never
3 Rarely
2 Most of the time
1 All of the time
A2. On average, how many days per week would you say that you missed at least one dose of your
medications?
1 Everyday
2 4_6 days/week
3 2_3 days/week
4 Once a week
5 Less than once a week
6 Never
A3. When was the last time you missed at least one dose of your medications?
1 Within the past week
2 1_2 weeks ago
3 3_4 weeks ago
4 Between 1 and 3 months ago
5 More than 3 months ago
6 Never
INDEX SCORE: _________
>10 =/good adherence
≤ 10 = poor adherence (Mannheimer et al., 2006)
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Appendix D

CONSENT TO PARTICIPATE IN RESEARCH
Standardized discharge medication education program for adults age 65 and older
You are asked to participate in a research study conducted by Jill Weller, doctoral candidate, at Research Medical
Center. You have been asked to participate in this study because you are aged 65 or older and being discharged
home with medications that may or may not be new to you. Approximately 26 total participants will be involved in
this study. You will receive in depth medication education at discharge, given educational handouts, and a pill
dispenser. You will be contacted and asked a series of questions one week following discharge, and again in three to
six weeks after discharge. Your participation in this study is entirely voluntary. You should read the information
below, and ask questions about anything you do not understand, before deciding whether or not to participate.


PURPOSE OF THE STUDY

The purpose of the study is to determine if focused education at performed at hospital discharge regarding home
medication use improves compliance.
 PROCEDURES
If you volunteer to participate in this study, and are in the intervention group, the education program will include the
following:
1. You will be given a pill dispenser.
2. You will be given medication information handouts listing how and when to take each medication, as well as
general information about each drug. These handouts will be written at an eighth grade reading level with large font
size.
3. You will be given a weekly/monthly calendar, plotting out the times of day all medications are to be taken.
 PARTICIPANT SELECTION
Participants will be placed into two groups, the intervention group and the standard care group. All participants will
be given a letter associated with their profile. Profile information will also include name, age, and gender.
 POTENTIAL RISKS AND DISCOMFORTS
This project involves protected health information. The principal investigator will have access to participant
medications and basic demographics for use in the data collection process. No names or participant identifiers will
be included in the final project.
The project will not involve any testing on individuals or manipulation of their medications. The primary purpose is
collecting data as it pertains to participant compliance or adherence to their prescribed regimen.


ANTICIPATED BENEFITS TO SUBJECTS

Improved understanding of home medication regimen, and/or improved medication compliance.


ANTICIPATED BENEFITS TO SOCIETY

The vision of the project is to have a positive effect on patient outcomes with an easy to use, standardized discharge
medication education regimen with minimal financial burden to the patient/client.


FINANCIAL OBLIGATION
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There is no financial obligation of the subject.


PRIVACY AND CONFIDENTIALITY

The only people who will know that you are a research subject are members of the research team and, if appropriate,
your physicians and nurses. No information about you, or provided by you during the research will be disclosed to
others without your written permission, except:
-

if necessary to protect your rights or welfare (for example, if you are injured and need
emergency care);
any threats that you make to harm yourself or others;
information that a child has been subjected to abuse or neglect; or
evidence of an infectious or contagious disease that endangers the public health will be
reported to appropriate authorities.

Profile information will include name, age, and gender. Patient data will be kept in a secure area to prevent
violations of patient privacy. For the purposes of this project, a secure area is defined as a password protected
computer and/or a locked file cabinet in the project lead’s home. No names or participant identifiers will be included
in the final project. When the results of the research are published or discussed in conferences, no information will
be included that would reveal your identity.
Authorized representatives of the HCA-Midwest Health System IRB may need to review records of individual
subjects. As a result, they may see your name; but they are bound by rules of confidentiality not to reveal your
identity to others.


PARTICIPATION AND WITHDRAWAL

Your participation in this research is VOLUNTARY. If you choose not to participate, that will not affect your
relationship with Research Medical Center, or your right to health care or other services to which you are otherwise
entitled. If you wish to withdraw from the study, you must do so in writing to the principal investigator, Jill Weller.
If you decide to participate, you are free to withdraw your consent and discontinue participation at any time without
prejudice to your future care at Research Medical Center.


WITHDRAWAL OF PARTICIPATION BY THE INVESTIGATOR

The investigator may withdraw you from participating in this research if circumstances arise which warrant doing
so. The principal investigator, Jill Weller, will make the decision and let you know if it is not possible for you to
continue.


NEW FINDINGS

During the course of the study, you will be informed of any significant new findings (either good or bad) that might
cause you to change your mind about continuing in the study. If new information is provided to you, your consent
to continue participating in this study will be re-obtained.


IDENTIFICATION OF INVESTIGATOR

In the event of a research related issue, or questions about the research, please contact the principal investigator Jill
Weller at (816) 678-8675.


RIGHTS OF RESEARCH SUBJECTS
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You may withdraw your consent at any time and discontinue participation without penalty. You are not waiving any
legal claims, rights or remedies because of your participation in this research study. If you have questions regarding
your rights as a research subject, you may contact Larry D. Cordell, MD, Chair of the HCA-Midwest Health System
Institutional Review Board at 816-246-3921.

SIGNATURE OF RESEARCH SUBJECT
I have read (or someone has read to me) and understand the information provided above. I have been given an
opportunity to ask questions and all of my questions have been answered to my satisfaction. I have been given a
copy of this form.
BY SIGNING THIS FORM, I WILLINGLY AGREE TO PARTICIPATE IN THE RESEARCH IT
DESCRIBES.
Subject’s name (print name)
Subject’s Signature
Date:

FOR SUBJECTS WHO CANNOT READ
The study subject has indicated that he/she is unable to read. The consent document has been read to the subject,
discussed with the subject, and the subject has been given an opportunity to ask questions of the study staff.

______________________________________
Printed Name of Impartial Witness

______________________________________
____________________________
Signature of Impartial Witness (if applicable)

Date

Impartial Witness: A person, who is independent of the trial, who cannot be unfairly influenced by people involved
with the trial, who attends the informed consent process if the subject or the subject’s legally acceptable
representative cannot read, and who reads the informed consent and any other written information supplied to the
subject. Guidance for Industry E6 Good Clinical Practice: Consolidated Guidance
SIGNATURE OF INVESTIGATOR/INTERVIEWER
I have explained the research to the subject or his/her legal representative and answered all of his/her questions.
________________________________________
Name of Investigator

________________________________________
Signature of Investigator

_____________________________
Date (must be the same as subjects)
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Appendix E
Weekly Medication Calendar
Monday

Levothyroxine 150mcg 6AM- 30-60 minutes prior to
breakfast
Sertraline 50 MG 9AM
Pravastatin 40mg 9PM
Percocet 1-2 tablets 6AM, Noon, 6PM, Midnight as needed
only

Tuesday

Levothyroxine 150mcg 6AM- 30-60 minutes prior to
breakfast
Sertraline 50 MG 9AM
Pravastatin 40mg 9PM
Percocet 1-2 tablets 6AM, Noon, 6PM, Midnight as needed
only

Wednesday

Levothyroxine 150mcg 6AM- 30-60 minutes prior to
breakfast
Sertraline 50 MG 9AM
Pravastatin 40mg 9PM
Percocet 1-2 tablets 6AM, Noon, 6PM, Midnight as needed
only

Thursday

Levothyroxine 150mcg 6AM- 30-60 minutes prior to
breakfast
Sertraline 50 MG 9AM
Pravastatin 40mg 9PM
Percocet 1-2 tablets 6AM, Noon, 6PM, Midnight as needed
only

Friday

Levothyroxine 150mcg 6AM- 30-60 minutes prior to
breakfast
Sertraline 50 MG 9AM
Pravastatin 40mg 9PM
Percocet 1-2 tablets 6AM, Noon, 6PM, Midnight as needed
only

Saturday

Levothyroxine 150mcg 6AM- 30-60 minutes prior to
breakfast
Sertraline 50 MG 9AM
Pravastatin 40mg 9PM
Percocet 1-2 tablets 6AM, Noon, 6PM, Midnight as needed
only

Sunday

Levothyroxine 150mcg 6AM- 30-60 minutes prior to
breakfast
Sertraline 50 MG 9AM
Pravastatin 40mg 9PM
Percocet 1-2 tablets 6AM, Noon, 6PM, Midnight as needed
only
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Appendix F
Sample Medication Education Handout (font size decreased for purposes of paper)
Drug #1
Sertraline: Sertraline is used to treat depression, panic attacks, obsessive compulsive disorder,
post-traumatic stress disorder, social anxiety disorder, and a severe form of premenstrual
dysphoric disorder. This medication may improve your mood, sleep, appetite, and energy level
and may help restore your interest in daily living. It may decrease fear, anxiety, and the number
of panic attacks. It may also reduce the urge to perform repeated tasks that interfere with daily
living. Sertraline is known as a selective serotonin reuptake inhibitor (SSRI). It works by helping
to restore the balance of a certain natural substance (serotonin) in the brain.
How to take: Take this medication by mouth as directed by your doctor, usually once daily
either in the morning or evening. This medication may be taken with or without food.
Benefits of adherence: Since untreated mental/mood problems (such as depression, panic
attacks, obsessive compulsive disorder, post-traumatic stress disorder) can be a serious condition,
do not stop taking this medication unless directed by your doctor. It is important to continue
taking this medication as prescribed even if you feel well. Do not stop taking this medication
without consulting your doctor.
Side effects: Nausea, dizziness, drowsiness, dry mouth, loss of appetite, increased sweating,
diarrhea, upset stomach, or trouble sleeping may occur. If any of these effects persist or worsen,
tell your doctor or pharmacist promptly. This drug may make you dizzy or drowsy. Do not drive,
use machinery, or do any activity that requires alertness until you are sure you can perform such
activities safely. Avoid alcoholic beverages.
Drug #2
Percocet: This combination medication is used to help relieve moderate to severe pain from your
surgical procedure. It contains a narcotic pain reliever (oxycodone) and a non-narcotic pain
reliever (acetaminophen). Oxycodone works in the brain to change how your body feels and
responds to pain. Acetaminophen can also reduce a fever.
How to take: Take this medication by mouth as directed by your doctor. You may take this drug
with or without food. If you have nausea, it may help to take this drug with food. Do not increase
your dose, take the medication more frequently, or take it for a longer time than prescribed
Benefits of adherence: Pain medications work best if they are used as the first signs of pain
occur. If you wait until the pain has worsened, the medication may not work as well. Along with
its benefits, this medication may rarely cause abnormal drug-seeking behavior (addiction). This
risk may be increased if you have abused alcohol or drugs in the past.
Side effects: Nausea, vomiting, constipation, lightheadedness, dizziness, or drowsiness may
occur. Some of these side effects may decrease over time. If any of these effects persist or
worsen, tell your doctor or pharmacist promptly. To prevent constipation, eat a diet adequate in
fiber, drink plenty of water, and exercise. Consult your pharmacist for help in selecting a laxative
(such as a stimulant type with stool softener).To reduce the risk of dizziness and lightheadedness,
get up slowly when rising from a sitting or lying position. This drug may make you dizzy or
drowsy. Do not drive, use machinery, or do any activity that requires alertness until you are sure
you can perform such activities safely. Avoid alcoholic beverages. Tell your doctor immediately
if any of these unlikely but serious side effects occur: mental/mood changes, severe
stomach/abdominal pain, difficulty urinating.
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Drug #3
Levothyroxine: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). It
replaces or provides more thyroid hormone, which is normally produced by the thyroid gland.
How to take: Take this medication by mouth as directed by your doctor, usually once daily on
an empty stomach, 30 minutes to 1 hour before breakfast. Take this medication with a full glass
of water unless your doctor directs you otherwise. If you are taking the capsule form of this
medication, swallow it whole. Do not split, crush, or chew. People who cannot swallow the
capsule whole should use the tablet form of the medication.
Benefits of adherence: Dosage is based on your age, weight, medical condition, laboratory test
results, and response to treatment. Use this medication regularly in order to get the most benefit
from it. To help you remember, take it at the same time each day. Do not stop taking this
medication without first consulting with your doctor. Thyroid replacement treatment is usually
taken for life. There are different brands of levothyroxine available. Do not change brands
without first consulting your doctor or pharmacist.
Side effects: Hair loss may occur during the first few months of treatment. This effect is usually
temporary as your body adjusts to this medication. If this effect persists or worsens, tell your
doctor or pharmacist promptly. Tell your doctor immediately if any of these unlikely but serious
effects of high thyroid hormone levels occur (too much medication): increased sweating,
sensitivity to heat, mental/mood changes (such as nervousness, mood swings), tiredness,
diarrhea, shaking (tremor), headache, shortness of breath.
Note: Some products that may interact with this drug include: "blood thinners" (such as
warfarin), digoxin, and theophylline.
Drug #4
Pravastatin: Pravastatin is used along with a proper diet to help lower "bad" cholesterol and fats
(such as LDL, triglycerides) and raise "good" cholesterol (HDL) in the blood. It belongs to a
group of drugs known as "statins." It works by reducing the amount of cholesterol made by the
liver. Lowering "bad" cholesterol and triglycerides and raising "good" cholesterol decreases the
risk of heart disease and helps prevent strokes and heart attacks.
How to take: Take this medication by mouth with or without food as directed by your doctor,
usually once daily. For best results, take this medication in the evening. Dosage is based on your
medical condition, response to treatment, age, and other medications you may be taking. If you
also take certain other drugs to lower your cholesterol (bile acid-binding resins such as
cholestyramine or colestipol), take pravastatin at least 1 hour before or at least 4 hours after
taking these medications. These products can react with pravastatin, preventing its full
absorption.
Benefits of adherence: Take this medication regularly in order to get the most benefit from it.
Remember to take it at the same time each day. It is important to continue taking this medication
even if you feel well. Most people with high cholesterol or triglycerides do not feel sick. It is
very important to continue to follow your doctor's advice about diet and exercise. It may take up
to 4 weeks before you get the full benefit of this drug.
Side effects: Many people using this medication do not have serious side effects. A very small
number of people taking pravastatin may have mild memory problems or confusion. If these rare
effects occur, talk to your doctor. Rarely, statins may cause or worsen diabetes. Talk to your
doctor about the benefits and risks. This drug may infrequently cause muscle problems
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(which can rarely lead to very serious conditions called rhabdomyolysis and autoimmune
myopathy). Tell your doctor right away if you develop any of these symptoms during
treatment and if these symptoms persist after your doctor stops this drug: muscle
pain/tenderness/weakness (especially with fever or unusual tiredness), change in the
amount of urine. This medication may rarely cause liver problems. If you notice any of the
following rare but serious side effects, tell your doctor immediately: yellowing eyes/skin, dark
urine, severe stomach/abdominal pain, persistent nausea/vomiting.
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Appendix G

Group Statistics
Control or Intervention
Question one week one

Question one week three

Question two week one

Question two week three

Question three week one

Question three week three

Total score week one

Total score week three

N

Mean

Std. Deviation

Std. Error Mean

Control

8

3.63

.518

.183

Intervention

8

3.75

.463

.164

Control

8

3.63

.518

.183

Intervention

8

3.88

.354

.125

Control

8

5.88

.354

.125

Intervention

8

5.88

.354

.125

Control

8

5.88

.354

.125

Intervention

8

5.88

.354

.125

Control

8

5.38

1.768

.625

Intervention

8

5.75

.707

.250

Control

8

5.50

1.414

.500

Intervention

8

5.75

.707

.250

Control

8

14.88

2.031

.718

Intervention

8

15.38

1.408

.498

Control

8

15.00

1.690

.598

Intervention

8

15.50

1.414

.500
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Appendix H

Independent Samples Test
Levene's Test
for Equality of
Variances

t-test for Equality of Means
95% Confidence
Interval of the

Sig.

F
Question

Equal

one week

variances

one

assumed

1.000

Sig.

.334

Difference

(2-

Mean

Std. Error

tailed)

Difference

Difference

14

.619

-.125

.245

-.652

.402

-.509 13.829

.619

-.125

.245

-.652

.402

14

.278

-.250

.222

-.725

.225

12.365

.281

-.250

.222

-.731

.231

14

1.000

.000

.177

-.379

.379

.000 14.000

1.000

.000

.177

-.379

.379

.000

14

1.000

.000

.177

-.379

.379

.000 14.000

1.000

.000

.177

-.379

.379

t

df

-.509

Lower

Upper

Equal
variances
not
assumed
Question

Equal

one week

variances

three

assumed

5.744

.031

1.128

Equal
variances

-

not

1.128

assumed
Question

Equal

two week

variances

one

assumed

.000

1.000

.000

Equal
variances
not
assumed
Question

Equal

two week

variances

three

assumed

.000

1.000

Equal
variances
not
assumed
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Question

Equal

three week variances
one

1.690

.215

-.557

14

.586

-.375

.673

-1.819

1.069

-.557

9.184

.591

-.375

.673

-1.893

1.143

-.447

14

.662

-.250

.559

-1.449

.949

-.447 10.294

.664

-.250

.559

-1.491

.991

-.572

14

.576

-.500

.874

-2.374

1.374

-.572 12.465

.577

-.500

.874

-2.396

1.396

-.642

14

.531

-.500

.779

-2.171

1.171

-.642 13.577

.532

-.500

.779

-2.176

1.176

assumed
Equal
variances
not
assumed

Question

Equal

three week variances
three

1.089

.314

assumed
Equal
variances
not
assumed

Total score Equal
week one

variances

.186

.673

assumed
Equal
variances
not
assumed
Total score Equal
week three variances

.044

.837

assumed
Equal
variances
not
assumed

